;(-)-Tetrahydrolipstatin

Create: 12/15/2016

Expired Date:	03/31/2016
Category:	Chemical
Message:	Medical uses: Orlistat is used for the treatment of obesity. The amount of weight loss achieved with orlistat varies. In one-year clinical trials, between 35.5% and 54.8% of subjects achieved a 5% or greater decrease in body mass, although not all of this mass was necessarily fat. Between 16.4% and 24.8% achieved at least a 10% decrease in body fat. After orlistat was stopped, a significant number of subjects regained weight-up to 35% of the weight they had lost. The incidence of type 2 diabetes in an obese population over four years is decreased with orlistat (6.2%) compared to placebo (9.0%).Long-term use of orlistat also leads to a modest reduction in blood pressure (mean reductions of 2.5 and 1.9 mmHg in systolic and diastolic blood pressure respectively).





City:	Wuhan Hubei[CN]
Location:

May 09 2017	Hot sell Steroid Powder Testosterone/T-base(CAS NO.:58-22-0)	542
May 02 2017	Tadalafil/Cialis(CAS NO: 171596-29-5)	569
May 02 2017	DHEA Dehydroepiandrosterone(CAS NO.:53-43-0)	489
May 02 2017	Clostebol Acetate(CAS NO.:855-19-6)	519
May 02 2017	Methenolone Enanthate (CAS NO.:303-42-4)	535
May 02 2017	Anabolic Steroid Powder Dianabol/Metandienone (CAS NO.:72-63-9)	576
May 01 2017	Steroid Oral Solution Mesterolone/Proviron 50	522
May 01 2017	Steroid Oil Solution Anomass 400	575
May 01 2017	Steroid Oral Solution Letrozole/Femara 5	574
May 01 2017	Steroid Oral Solution Anastrozole/Arimidex 5	586